Media Releases
News Articles
Research
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research
Precision oncology firm, Lucence, with Diagnostics Development Hub (DxD Hub), hosted by the Agency for Science, Technology and Research (A*STAR), Singapore and the National Cancer Centre Singapore (NCCS), officially launched UNITED 2.0, a S$6 million research collaboration to develop a next-generation, clinical grade cancer profiling test with the goal of advancing the future of precision diagnostics.
13 Mar 2026
Read Story
Patient Care
Lifestyle-driven cancer risk persists despite Singapore’s prevention efforts here: Oncologists
SINGAPORE – Lifestyle-related risk factors may increase the prevalence of cancer cases here, despite Singapore’s strong cancer prevention policies, said oncologists.
09 Mar 2026 |
The Straits Times
Read Story
Patient Care
为防癌自费切除子宫卵巢 慈母拟用终身健保保健储蓄进行预防性切乳术
当得知自己体内潜藏基因突变，面临更高遗传性乳腺癌和卵巢癌风险时，今年44岁的阳女士，毅然自费切除了子宫和卵巢，并计划切除双乳。
06 Mar 2026 |
Lianhe Zaobao
Read Story
Patient Care
Singapore’s cancer screening gap is widening at a critical moment
Low participation rates, late diagnoses and younger patients point to the urgent need for a rethink.
05 Feb 2026 |
The Straits Times
Read Story
Our Publications
Stay Healthy The Easy Way
Get trusted health advice, offers and more.
Stay Ahead in Healthcare Industry
Subscribe to our exclusive updates for healthcare professionals.
Keep Healthy With
Follow NCCS
© 2025 SingHealth Group. All Rights Reserved.